Asymmetrex approved by the ASTM International to conduct an interlab evaluation of its AlphaSTEM Test™ stem cell-specific counting technology as a standard for the stem cell medicine industry. Read More
Read the latest news from the MassBio community! This space is for members to share company updates and press releases. Members may not post stories that are copyrighted by news publications or post sales pitches.
In November 2018, Asymmetrex presented its stem cell counting technology to ASTM staff for evaluation as an ASTM standard. Today, the company presented a proposal for an interlab study of its test. Read More
Asymmetrex begins new effort to increase awareness of the continuing need for specific and accurate counting of perinatal and postnatal tissue stem cells for stem cell research and stem cell medicine. Read More
Pubicis Health Solutions Releases New White Paper: What Physicians Want - Understanding Biologics & Biosimilar Prescribers Read More
Asymmetrex founder and director James Sherley addresses the importance and challenges of introducing stem cell dose standardization into regenerative medicine practice. Read More
Stem cell biotechnology company Asymmetrex and preclinical toxicology CRO DRIK have formed a new partnership for addressing a significant unmet need in the pharmaceutical and cell therapy industries. Read More
President Trump and U.S. Department of Health and Human Services (HHS) Secretary Alex Azar delivered highly anticipated speeches regarding the Administration's plan to reduce drug prices. Read More